Search research articles
Contact Us
Filters
Showing results (151-160 of 268) with videos related to
Page
of 27
Sort By:
Frontiers in Pediatrics
|
August 23, 2014
Targeting Glutathione S-transferase M4 in Ewing sarcoma
Rupeng Zhuo, Kenneth M Kosak, Savita Sankar, et al.
Bone Marrow Transplantation
|
January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience
Jeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Oncotarget
|
August 28, 2020
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
Yaya Chu, Aradhana Awasthi, Sanghoon Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study
Erin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 6, 2009
Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents
Thomas G Gross, Gregory A Hale, Wensheng He, et al.
Blood
|
February 28, 2002
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
Jon J van Rood, Fausto R Loberiza, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 30, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types
Saeed Ahmad, Kun Xing, Marcelo S F Pereira, et al.
British Journal of Haematology
|
May 6, 2017
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report
Sanghoon Lee, Nancy S Day, Rodney R Miles, et al.
British Journal of Haematology
|
July 29, 2014
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report
Stanton Goldman, Lynette Smith, Paul Galardy, et al.
British Journal of Haematology
|
November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961
Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 268) with videos related to
Sort By:
Page
of 27
Frontiers in Pediatrics
|
August 23, 2014
Targeting Glutathione S-transferase M4 in Ewing sarcoma
Rupeng Zhuo, Kenneth M Kosak, Savita Sankar, et al.
Bone Marrow Transplantation
|
January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience
Jeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Oncotarget
|
August 28, 2020
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
Yaya Chu, Aradhana Awasthi, Sanghoon Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study
Erin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 6, 2009
Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents
Thomas G Gross, Gregory A Hale, Wensheng He, et al.
Blood
|
February 28, 2002
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
Jon J van Rood, Fausto R Loberiza, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 30, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types
Saeed Ahmad, Kun Xing, Marcelo S F Pereira, et al.
British Journal of Haematology
|
May 6, 2017
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report
Sanghoon Lee, Nancy S Day, Rodney R Miles, et al.
British Journal of Haematology
|
July 29, 2014
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report
Stanton Goldman, Lynette Smith, Paul Galardy, et al.
British Journal of Haematology
|
November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961
Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Page
of 27